Drugs / Mesenchymal stem cell transplantation
Mesenchymal stem cell transplantation
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT02943889 | Oct 2016 → Jun 2017 | cirrhosis of liver | Assiut University | Unknown | No outcome recorded |
| Phase 2/31 trial · 1 met primary | ||||||
| Phase 2/3 | NCT01759823 | Dec 2012 → Dec 2014 | type 2 diabetes mellitus | Post Graduate Institute of Medical Education and Research, Chandigarh | Completed | Met primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | mesenchymal stem cell transplantation | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01759823 ↗ |
| Modality | Cell therapy | “Stem cell therapy has emerged as a novel therapeutics strategy to target β-cells” PMID 28690682 ↗ Jul 2017 |
| Route | Other | “mesenchymal stem cell will be injected into superior pancreatic duodenal artery .” NCT01759823 ↗ |